A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Clinical trial NCT06819891 · RECRUITING
Trial details
- NCT number
- NCT06819891
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-12
- Primary completion
- 2028-12-31
- Enrollment
- 425
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.